<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Hoth Therapeutics, Inc.

    Hoth Therapeutics, Inc.

    Hoth Therapeutics is a development stage biopharmaceutical company focused on prop...

    Hoth Therapeutics is a development stage biopha...

    Filing Type:    PU
    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental...

    Pluristem Therapeutics Inc. is a clinical-stage...

    Filing Type:    PU
    Bot Image, Inc.

    Bot Image, Inc.

    Bot Image has developed ProstatID, aiding in the early diagnosis of prostate cance...

    Bot Image has developed ProstatID, aiding in th...

    Amount Raised:    $61,598
    Fundraising Status:    EC
    Filing Type:    CF
    TherapeuticsMD, Inc.

    TherapeuticsMD, Inc.

    TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed...

    TherapeuticsMD, Inc. is an innovative pharmaceu...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused o...

    Mirum Pharmaceuticals Inc. is a clinical-stage ...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    Curis, Inc.

    Curis, Inc.

    Curis is a biotechnology company focused on the development and commercialization ...

    Curis is a biotechnology company focused on the...

    Filing Type:    PU
    MEI Pharma, Inc.

    MEI Pharma, Inc.

    MEI Pharma (Nasdaq: MEIP) is a San Diego-based late-stage pharmaceutical company f...

    MEI Pharma (Nasdaq: MEIP) is a San Diego-based ...

    Filing Type:    PU
    Theravance Biopharma, Inc.

    Theravance Biopharma, Inc.

    Theravance Biopharma is a diversified biopharmaceutical company with the core purp...

    Theravance Biopharma is a diversified biopharma...

    Filing Type:    PU
    Galapagos NV

    Galapagos NV

    Galapagos develops therapies with proprietary, novel modes-of-action. Filgotinib, ...

    Galapagos develops therapies with proprietary, ...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.